We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Decreased risk of breast cancer associated with oral bisphosphonate therapy.
- Authors
Mathew, Aju; Brufsky, Adam
- Abstract
Preclinical studies and adjuvant trials using bisphosphonates have found them to have an antitumor effect. Although major advances have been made in chemoprevention strategies with selective estrogen receptor modulators and aromatase inhibitors, their use has been fraught with significant adverse effects such as venous thromboembolic events and an increased risk for endometrial cancer. In this context, several recent observational studies have investigated a chemoprevention role for oral bisphosphonates in decreasing risk for breast cancer. This review will aim to summarize these studies and present a critical evaluation of the association between oral bisphosphonate use and breast cancer risk reduction.
- Subjects
BREAST cancer; DISEASE risk factors; DIPHOSPHONATES; AROMATASE inhibitors; CHEMOPREVENTION
- Publication
Breast Cancer: Targets & Therapy, 2012, Vol 4, p75
- ISSN
1179-1314
- Publication type
Article
- DOI
10.2147/BCTT.S16356